Clinical Pharmacy

Posts that discuss a wide range of pharmacy topics with clinical knowledge, references, and experience included!

Clinical Pharmacy

Penicillin Panic: Are You Really Allergic?

Many penicillin allergy labels are inaccurate, creating barriers to care. Learn how tools like PEN-FAST help de-label and improve treatment.

Members only

Clinical Pharmacy

HIV: Clinical Tips

Members only

Clinical Pharmacy

Let's Talk Vancomycin: Part 2

Clinical Pharmacy

Emergency Medicine Review: TBI Management

Overview of key TBI pharmacotherapy: RSI, sedation, hemodynamics, hyperosmolar therapy, seizure & anticoagulant management for acute care. Robbins 2025 AJEM article discussed.

Clinical Pharmacy

Hematological Malignancies: Diffuse Large B-Cell Lymphoma (DLBCL)

This article provides a high-level overview of the evolution of DLBCL treatment, unmet clinical needs, diagnosis, immunophenotyping, and future therapeutic innovations.

Members only

Clinical Pharmacy

Let's Talk Vancomycin: Part 1

Clinical Pharmacy

Opportunistic Infections: Pneumocystis jirovecii Pneumonia (PJP)

Our first clinical pharmacy article of the year is a high-level overview of pneumocystis jiroveci pneumonia, or PJP (aka PCP). Stay tuned for future opportunistic infection posts!

Health and Wellness

Wearable Wellness: How the Oura Ring May Enhance Patient Care in Pharmacy Practice

By focusing on sleep, health metrics, and activity, the Oura Ring may provide a holistic approach to health tracking.

Paid-members only

Clinical Pharmacy

Aminoglycoside Peak/Trough Interpretations

This past month, I had the pleasure to co-precept a pharmacy resident on an Antimicrobial Stewardship (AMS) rotation. Being a (mostly) outpatient HIV pharmacist for the last 10 months, I was both excited and nervous. What aspects of AMS could I cover from an HIV/outpatient perspective? Oh, how I

Clinical Pharmacy

Finding Nemolizumab in Prurigo Nodularis

Nemolizumab, when administered every 4 weeks, saw a statistically significant improvement in itch relief and IGA treatment success at Week 16, with results as early as 4 weeks, sustained/improvement through Week 24, and a relatively favorable safety profile.

Clinical Pharmacy

Cryptogenic Stroke: Part 2

Even when it was happening, I was convinced that it could not be a stroke, that it had to be something else, even though I had the three hallmark signs (arm weakness, facial droop, slurred speech).

Members only

Clinical Pharmacy

Hypertensive Emergencies (Part 2)

Members only

Clinical Pharmacy

Hypertensive Emergencies (Part 1)

Members only

Journal Clubs

INSPIRES Trial (Statin Results)

Paid-members only

Clinical Pharmacy

REDUCE-AMI Journal Club

We break down evidence-based medicine so you don't have to! This journal club will discuss the new REDUCE-AMI trial that is hot in the cardiology literature right now.

Clinical Pharmacy

Should You Take Ozempic For Weight Loss?

The goal of this article is not to dissuade you from taking a GLP-1 agonist for weight loss, and it's probably an appropriate option for many. However, it is definitely NOT the right option for everyone.

Clinical Pharmacy

Should Clinical Trial Results Expire? REDUCE-AMI Study

The findings of this study were rather damning. In essence, the study found NO BENEFIT from adding long-term beta-blocker treatment in patients with acute myocardial infarction (MI) who have a preserved ejection fraction.

Clinical Pharmacy

Migraines: A Quick Guide

Quick topic discussion on migraine, pathophysiology, and tables regarding medication treatment options (for acute and preventative management).

Members only

Clinical Pharmacy

Antiepileptics with RX Cheatsheets

Members only

Clinical Pharmacy

INSPIRES Trial (DAPT Results)

Clinical Pharmacy

Drug-Induced Thrombocytopenia

Drug-induced thrombocytopenia is just what it sounds like: low platelet counts due to a side effect of a medication. Join us in learning about some key culprit drug and how to manage these cases!

Members only

Clinical Pharmacy

ARTESIA Trial

Members only

Clinical Pharmacy

Censoring in Clinical Trials: Survival Analysis

Clinical Pharmacy

Interview: Cryptogenic Stroke in 29 Year Old

We can't thank Alex enough for turning his difficult experience into a learning opportunity for pharmacists and patients alike!

Clinical Pharmacy

Exploring the Unknown: Cryptogenic Stroke

Strokes always have a source of origin and a cause, right? Wrong. Sometimes in medicine, there isn't an etiology. One example, cryptogenic stroke.